Your browser is no longer supported. Please, upgrade your browser.
HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsElite Help
publish chart | save to portfolio | create alert Type: candle | line | advanced | interactive | perf    Timeframe: intraday | daily | weekly | monthly  Settings
QTRX Quanterix Corporation daily Stock Chart
QTRX [NASD]
Quanterix Corporation
Healthcare | Biotechnology | USA
statements
Index- P/E- EPS (ttm)-1.64 Insider Own9.40% Shs Outstand26.90M Perf Week23.17%
Market Cap539.08M Forward P/E- EPS next Y-1.30 Insider Trans-4.31% Shs Float25.55M Perf Month-15.55%
Income-40.80M PEG- EPS next Q-0.41 Inst Own86.30% Short Float5.63% Perf Quarter-13.32%
Sales56.70M P/S9.51 EPS this Y-13.40% Inst Trans4.37% Short Ratio9.31 Perf Half Y0.30%
Book/sh4.59 P/B4.37 EPS next Y16.10% ROA-31.40% Target Price33.00 Perf Year-19.19%
Cash/sh4.06 P/C4.94 EPS next 5Y- ROE-43.60% 52W Range10.90 - 36.15 Perf YTD-15.19%
Dividend- P/FCF- EPS past 5Y- ROI-30.40% 52W High-44.56% Beta-
Dividend %- Quick Ratio6.20 Sales past 5Y- Gross Margin47.30% 52W Low83.94% ATR2.38
Employees248 Current Ratio6.70 Sales Q/Q45.90% Oper. Margin-73.60% RSI (14)53.66 Volatility13.71% 16.77%
OptionableNo Debt/Eq0.06 EPS Q/Q7.00% Profit Margin-71.90% Rel Volume1.20 Prev Close19.21
ShortableYes LT Debt/Eq0.06 EarningsMar 09 AMC Payout- Avg Volume154.69K Price20.04
Recom- SMA2018.72% SMA50-11.76% SMA200-19.60% Volume186,051 Change4.32%
Mar-27-20 09:45AM  Quanterix Statement on COVID-19 Preparedness, Resiliency Efforts and Business Continuity Business Wire
Mar-11-20 08:13AM  Quanterix Corporation Annual Results: Here's What Analysts Are Forecasting For Next Year Simply Wall St. -6.52%
Mar-09-20 04:05PM  Quanterix Corporation Releases Operating Results for Fourth Quarter and Full Year 2019 Business Wire -9.30%
Feb-21-20 04:32PM  Quanterix Corporation to Release Fourth Quarter 2019 Financial Results on March 9, 2020 and Present at Multiple Upcoming Healthcare Conferences Business Wire
Feb-11-20 11:44AM  Quanterix (NASDAQ:QTRX) Is Using Debt Safely Simply Wall St.
Jan-31-20 10:04AM  Quanterix Simoa Technology Advances the Field Toward a Sports-Related Concussion Blood Test Business Wire
Jan-10-20 02:03PM  Quanterix Corporation to Present at 38th Annual J.P. Morgan Healthcare Conference Business Wire
Dec-19-19 04:23PM  Hedge Funds Have Never Been This Bullish On Quanterix Corporation (QTRX) Insider Monkey
Dec-11-19 10:27AM  Does The Quanterix Corporation (NASDAQ:QTRX) Share Price Fall With The Market? Simply Wall St.
Nov-06-19 04:01PM  Quanterix Corporation Releases Operating Results for Third Quarter 2019 Business Wire -5.07%
Nov-04-19 04:00PM  Siemens Healthineers Enters into License and Supply Arrangement with Quanterix for Access to Neurofilament Light (Nf-L) Antibodies to Develop Nf-L Assays Business Wire
Nov-01-19 09:41AM  Hedge Funds Have Never Been More Bullish On Quanterix Corporation (QTRX) Insider Monkey
Oct-25-19 09:13AM  Quanterix Simoa Technology Unlocks Low-Level Markers Critical to Rapid Triage Test in Study for Active Pulmonary Tuberculosis Business Wire
Oct-22-19 04:30PM  Quanterix to Release Third Quarter 2019 Financial Results and Host Conference Call on November 6, 2019 Business Wire
Oct-18-19 11:13AM  3 Medical Product Stocks Likely to Beat This Earnings Season Zacks
Oct-03-19 09:00AM  Quanterix Announces Recipients of Annual Accelerator Grant Program Business Wire +11.06%
Oct-01-19 09:46AM  Need To Know: Quanterix Corporation (NASDAQ:QTRX) Insiders Have Been Selling Shares Simply Wall St.
Sep-26-19 07:00AM  Sherlock Bio gets DoD grant to bring CRISPR to the battlefield American City Business Journals
Sep-24-19 01:14PM  Powering Precision Health Announces 2019 Summit Business Wire -5.86%
Sep-16-19 06:21PM  Quanterix Serum Nf-L Assay Powers Key Trial and Study Results Presented at ECTRIMS 2019 Business Wire
Sep-11-19 08:00AM  Quanterix Simoa Technology Powers Multiple Sclerosis Research with More Than 50 Presentations at ECTRIMS 2019 Business Wire +7.48%
Aug-13-19 04:21PM  Quanterix Announces Closing of Public Offering Including Exercise of Underwriters Option to Purchase Additional Shares Business Wire
Aug-09-19 07:45AM  Quanterix Prices Public Offering of Common Stock Business Wire
Aug-07-19 04:23PM  Quanterix Announces Proposed Public Offering of Common Stock Business Wire
08:25AM  Quanterix Corporation (QTRX) Q2 2019 Earnings Call Transcript Motley Fool
Aug-06-19 08:30AM  Quanterix Corporation Releases Operating Results for Second Quarter 2019 Business Wire
Jul-31-19 09:00AM  Quanterix to Present at the Canaccord Genuity 39th Annual Growth Conference Business Wire
Jul-30-19 10:30AM  Quanterix to Release Second Quarter 2019 Financial Results and Host Conference Call on Tuesday, August 6, 2019 Business Wire
Jul-26-19 11:16AM  Sarah Hlavinka Elected to Quanterix Board of Directors Business Wire
Jul-11-19 01:30PM  Quanterix to Convene Leading Industry Researchers at Alzheimers Association International Conference 2019 Following Closing of UmanDiagnostics Acquisition Business Wire
Jun-28-19 12:15PM  Quanterix Announces Kevin Hrusovsky, Chairman and Chief Executive Officer, and Founder of Powering Precision Health, as EY Entrepreneur Of The Year® 2019 Award Winner in New England Business Wire
Jun-27-19 10:43AM  Mass. diagnostics firms sign M&A deals worth $500M American City Business Journals +8.95%
Jun-26-19 04:00PM  Quanterix Announces Agreement to Acquire UmanDiagnostics, Worlds Leading Neurofilament Light (Nf-L) Antibody Supplier Business Wire
Jun-06-19 07:03AM  Did Quanterix's (NASDAQ:QTRX) Share Price Deserve to Gain 66%? Simply Wall St.
Jun-04-19 04:00PM  Quanterix Raises $49.7 Million and Announces Introduction of Latest Model Simoa HD-X Analyzer at BIO 2019 International Convention Business Wire
May-29-19 04:00PM  Quanterix Expands Headquarters to New, State-of-the-Art Facility in Billerica, Mass. as Demand Continues to Grow for its Disruptive Simoa Platforms Business Wire
May-16-19 10:30AM  Quanterix Announces $50,000 in Grants to Support Promising Oncology Research Business Wire
May-11-19 01:27PM  Heres What Hedge Funds Think About Quanterix Corporation (QTRX) Insider Monkey
May-10-19 11:23AM  Quanterix Corporation (QTRX) Q1 2019 Earnings Call Transcript Motley Fool
May-09-19 04:00PM  Quanterix Corporation Releases Operating Results for First Quarter 2019 Business Wire
May-06-19 11:30AM  Quanterix Simoa Technology Powers More Than 85 Percent of Neurofilament Light Biomarker Research to be Unveiled at American Academy of Neurology Annual Meeting Business Wire
May-02-19 04:00PM  Quanterix to Release First Quarter 2019 Financial Results and Host Conference Call on Thursday, May 9, 2019 Business Wire
Apr-01-19 07:14AM  Will Quanterix Corporation's (NASDAQ:QTRX) Earnings Grow In The Next Couple Of Years? Simply Wall St. -9.41%
Mar-28-19 04:00PM  Quanterix Appoints Amol Chaubal as Chief Financial Officer Business Wire
Mar-18-19 05:48PM  Quanterix Corp (QTRX) Files 10-K for the Fiscal Year Ended on December 31, 2018 GuruFocus.com
Mar-08-19 01:15AM  Quanterix Corporation (QTRX) Q4 2018 Earnings Conference Call Transcript Motley Fool
Mar-07-19 04:00PM  Quanterix Corporation Releases Operating Results for Fourth Quarter and Full Year 2018 Business Wire
Feb-26-19 04:00PM  Quanterix to Release Fourth Quarter and Full Year 2018 Financial Results and Host Conference Call on Thursday, March 7, 2019 Business Wire
Feb-21-19 02:45PM  Quanterix to Present at Multiple Upcoming Healthcare Conferences Business Wire
Feb-19-19 06:04AM  Could a blood test predict Alzheimer's disease 16 years before symptoms? American City Business Journals
Jan-14-19 11:45AM  Quanterix to Present at 21st Annual Needham Growth Conference Business Wire -6.43%
Jan-10-19 12:00PM  Quanterix Extends Oncology Footprint with Accelerated Launch of Next Gen SP-X Platform and CorPlex Validated 10-Plex Business Wire +9.31%
Jan-04-19 04:17PM  Quanterix Marks One-Year Anniversary of IPO with Key Milestones Accelerating Healthcare Disruption Ahead of Presentation at the 37th Annual J.P. Morgan Healthcare Conference Business Wire
Dec-20-18 10:11AM  Have Insiders Been Selling Quanterix Corporation (NASDAQ:QTRX) Shares This Year? Simply Wall St.
Dec-13-18 03:08PM  Facing headwinds, medtech sector won't be left to its own devices American City Business Journals
Nov-26-18 01:00PM  Quanterix to Present at the Evercore ISI HealthCONx Conference Business Wire
Nov-21-18 08:15AM  Factors of Influence in 2018, Key Indicators and Opportunity within Okta, One Horizon Group, Vivopower International Plc, PetIQ, Quanterix, and Eidos Therapeutics New Research Emphasizes Economic Growth GlobeNewswire
Nov-13-18 04:00PM  Quanterix to Present at the Canaccord Genuity Medical Technologies & Diagnostic Forum Business Wire
Nov-07-18 09:00AM  Quanterix Expanding Transformative Biomarker Technology Portfolio Into Oncology Business Wire
Nov-01-18 04:00PM  Quanterix Corporation Releases Operating Results for Third Quarter 2018 Business Wire
Oct-25-18 04:05PM  Quanterix to Release Third Quarter 2018 Financial Results and Host Conference Call on Thursday, November 1, 2018 Business Wire
Oct-22-18 04:30PM  Quanterix Announces Collaboration with OncoGenesis to Develop Cervical Screening Test Business Wire
Oct-09-18 12:00AM  Quanterix Simoa Technology Powers Record Number of Presentations and Poster Sessions at ECTRIMS 2018 Business Wire
Sep-26-18 09:00AM  Quanterix Simoa Technology Reveals Link Between Soccer Headers and Concussions for the First Time Business Wire +7.23%
Sep-18-18 10:45AM  Quanterix CEO Leads Webinar on How Digital Biomarkers are Empowering Drug Development Business Wire +12.34%
Sep-12-18 05:15PM  Quanterix Announces Termination of License Agreement with bioMérieux Business Wire
Sep-05-18 09:00AM  Quanterix to Speak at Wells Fargo Securities 2018 Healthcare Conference Business Wire
Aug-08-18 04:00PM  Quanterix Corporation Releases Operating Results for Second Quarter 2018 Business Wire
Aug-06-18 09:32AM  Simoa Technology Unlocks Insights from Previously Obscure Biomarker Business Wire
Jul-30-18 09:00AM  Quanterix to Present at the Canaccord Genuity 38th Annual Growth Conference Business Wire
Jul-26-18 09:00AM  Quanterix to Release Second Quarter 2018 Financial Results and Host Conference Call on Wednesday, August 8, 2018 Business Wire
Jul-23-18 01:00PM  Quanterix Ultra-Sensitive Technology Creates Breakthroughs in Brain Health of Military and Veterans Business Wire
Jun-13-18 09:30AM  EY Announces Kevin Hrusovsky, President, Chairman and Chief Executive Officer of Quanterix and Founder of Powering Precision Health as an Entrepreneur Of The Year® 2018 Award Finalist in the New England Region Business Wire
May-09-18 04:00PM  Quanterix Corporation Releases Operating Results for First Quarter 2018 Business Wire
May-02-18 09:00AM  Quanterix to Release First Quarter 2018 Financial Results and Host Conference Call on Wednesday, May 9, 2018 Business Wire
Apr-27-18 09:00AM  Quanterix Marks Leadership in Accelerating Neurology Research with 100-Publication Milestone Business Wire
Mar-21-18 11:00AM  Quanterix to Present at Needham and Companys 17th Annual Healthcare Conference Business Wire
Mar-20-18 09:00AM  Quanterix Corporation and DestiNA Genomics to Collaborate in Effort to Transform microRNA Biomarker Detection Business Wire
Mar-14-18 04:05PM  Quanterix Corporation Releases Operating Results for Fourth Quarter and Fiscal Year 2017 Business Wire
Mar-08-18 08:00AM  New Research Demonstrates Enhanced Sensitivity for Acute HIV Detection Using Quanterix Simoa Technology Business Wire
Mar-07-18 12:56PM  Quanterix to Present at the Cowen and Company 38th Annual Healthcare Conference Business Wire
Feb-08-18 10:00AM  Quanterix to Present at The LEERINK Partners 7th Annual Global Healthcare Conference Business Wire
Jan-22-18 04:52PM  Quanterix Uses JPMorgan Healthcare Conference to Scout Sales Candidates TheStreet.com
Jan-04-18 09:03AM  Quanterix Corporation to Present at 36th Annual J.P. Morgan Healthcare Conference Business Wire
Jan-02-18 11:35AM  Quanterix Announces Commercial Availability of New SR-X Ultra-Sensitive Biomarker Detection System Business Wire
Dec-13-17 06:15PM  Quanterix Corp (QTRX) EC, President & CEO E Kevin Hrusovsky Bought $510,000 of Shares GuruFocus.com
Quanterix Corporation, a life sciences company, develops and markets ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific. The company offers Simoa HD-1 instrument, a sensitive automated multiplex protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection technology in various applications, including direct detection of nucleic acids. It also develops SP-X instrument that is based on Simoa planar array technology for the measurement of multiplex chemiluminescent immunoassays. The company's products include kits, such as beads, capture and detector reagents, enzyme reagents, and enzyme substrates to run tests; and consumables, such as proprietary Simoa disks, cuvettes, and disposable tips. In addition, it offers contract research services, including sample testing, homebrew assay development, and custom development services. The company primarily operates in the areas of neurology, oncology, cardiology, infectious diseases, and inflammation. It sell its products for the life science research sector primarily to laboratories associated with academic and governmental research institutions, as well as pharmaceutical, biotechnology, and contract research companies through a direct sales force, support organizations, and distributors or sales agents. The company was formerly known as Digital Genomics, Inc. and changed its name to Quanterix Corporation in August 2007. Quanterix Corporation was incorporated in 2007 and is headquartered in Billerica, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
HRUSOVSKY E KEVINChairman, President & CEOApr 01Sale17.443,23356,3991,137,367Apr 02 05:00 PM
Mattoon DawnSr. VP, Research ProductsApr 01Sale17.44971,69232,469Apr 02 04:54 PM
Roskey Mark T.SVP, Commercial & AcceleratorMar 31Sale17.44931,62221,836Apr 01 07:52 PM
Roskey Mark T.SVP, Commercial & AcceleratorMar 30Option Exercise2.965,00014,80026,929Apr 01 07:52 PM
Roskey Mark T.SVP, Commercial & AcceleratorMar 30Sale18.005,00090,00021,929Apr 01 07:52 PM
Duffy David C.SVP R&D and CTOMar 19Sale11.461,66719,10454,526Mar 20 05:03 PM
WALT DAVID RDirectorMar 13Buy16.6654,064900,9121,276,374Mar 17 04:12 PM
Roskey Mark T.SVP, Commercial & AcceleratorMar 13Sale16.045669,08121,929Mar 17 04:12 PM
Mattoon DawnSr. VP, Research ProductsMar 13Sale16.045669,08132,566Mar 17 04:12 PM
HRUSOVSKY E KEVINChairman, President & CEOMar 10Sale20.535,500112,9151,140,600Mar 12 04:12 PM
Madaus Martin DDirectorMar 05Option Exercise1.931,6003,08811,202Mar 06 05:46 PM
Madaus Martin DDirectorMar 05Sale22.052,30050,724183,566Mar 06 05:46 PM
Madaus Martin DDirectorMar 05Sale22.991,60036,7849,602Mar 06 05:46 PM
Madaus Martin DDirectorMar 04Option Exercise1.931,6003,08811,202Mar 06 05:46 PM
Madaus Martin DDirectorMar 04Sale23.592,30054,247185,866Mar 06 05:46 PM
Madaus Martin DDirectorMar 04Sale23.471,60037,5529,602Mar 06 05:46 PM
HRUSOVSKY E KEVINChairman, President & CEOMar 02Sale22.668,830200,0801,146,100Mar 04 08:50 PM
Mattoon DawnSr. VP, Research ProductsMar 02Sale22.931152,63633,132Mar 04 04:49 PM
Roskey Mark T.SVP, Commercial & AcceleratorMar 02Sale22.93461,05522,495Mar 04 04:49 PM
Madaus Martin DDirectorFeb 21Option Exercise1.931,6003,08811,202Feb 21 07:14 PM
Madaus Martin DDirectorFeb 21Sale27.982,30064,359188,166Feb 21 07:14 PM
Madaus Martin DDirectorFeb 21Sale28.261,60045,2169,602Feb 21 07:14 PM
Madaus Martin DDirectorFeb 20Option Exercise1.931,6003,08811,202Feb 21 07:14 PM
Madaus Martin DDirectorFeb 20Sale28.132,30064,705190,466Feb 21 07:14 PM
Madaus Martin DDirectorFeb 20Sale28.291,60045,2669,602Feb 21 07:14 PM
Roskey Mark T.SVP, Commercial & AcceleratorFeb 18Option Exercise2.965,00014,80019,184Feb 20 08:18 PM
Roskey Mark T.SVP, Commercial & AcceleratorFeb 18Sale27.845,000139,19414,184Feb 20 08:18 PM
HRUSOVSKY E KEVINChairman, President & CEOFeb 12Sale27.176,500176,6141,115,933Feb 14 07:58 PM
Duffy David C.SVP R&D and CTOFeb 11Sale27.881,66746,47649,693Feb 11 04:50 PM
HRUSOVSKY E KEVINChairman, President & CEOFeb 06Sale27.566,500179,1401,122,433Feb 07 04:15 PM
Madaus Martin DDirectorFeb 05Option Exercise1.931,6003,08811,202Feb 06 04:44 PM
Madaus Martin DDirectorFeb 05Sale27.652,30063,594192,766Feb 06 04:44 PM
Madaus Martin DDirectorFeb 05Sale27.701,60044,3209,602Feb 06 04:44 PM
Madaus Martin DDirectorFeb 04Option Exercise1.931,6003,08811,202Feb 06 04:44 PM
Madaus Martin DDirectorFeb 04Sale26.952,30061,988195,066Feb 06 04:44 PM
Madaus Martin DDirectorFeb 04Sale26.521,60042,4329,602Feb 06 04:44 PM
Roskey Mark T.SVP, Commercial & AcceleratorFeb 04Sale26.71551,46914,184Feb 04 05:49 PM
Mattoon DawnSr. VP, Research ProductsFeb 04Sale26.711373,65922,104Feb 04 05:47 PM
HRUSOVSKY E KEVINChairman, President & CEOFeb 04Sale26.712,40964,3441,128,933Feb 05 04:28 PM
HRUSOVSKY E KEVINChairman, President & CEOFeb 03Sale27.096,500176,0571,131,342Feb 05 04:28 PM
HRUSOVSKY E KEVINChairman, President & CEOJan 29Sale26.996,500175,4071,137,842Jan 29 07:54 PM
Madaus Martin DDirectorJan 23Option Exercise1.931,6003,08811,202Jan 24 04:34 PM
Madaus Martin DDirectorJan 23Sale25.602,30058,875197,366Jan 24 04:34 PM
Madaus Martin DDirectorJan 23Sale24.861,60039,7769,602Jan 24 04:34 PM
Madaus Martin DDirectorJan 22Option Exercise1.931,6003,08811,202Jan 24 04:34 PM
Madaus Martin DDirectorJan 22Sale25.432,30058,484199,666Jan 24 04:34 PM
Madaus Martin DDirectorJan 22Sale25.151,60040,2409,602Jan 24 04:34 PM
Roskey Mark T.SVP, Commercial & AcceleratorJan 21Option Exercise2.965,00014,80019,239Jan 22 05:12 PM
HRUSOVSKY E KEVINChairman, President & CEOJan 21Sale24.076,500156,4441,144,342Jan 22 05:12 PM
Roskey Mark T.SVP, Commercial & AcceleratorJan 21Sale24.045,000120,18214,239Jan 22 05:12 PM
Duffy David C.SVP R&D and CTOJan 17Option Exercise1.931,9413,74653,301Jan 17 08:46 PM
Duffy David C.SVP R&D and CTOJan 17Sale23.991,94146,56551,360Jan 17 08:46 PM
HRUSOVSKY E KEVINChairman, President & CEOJan 17Sale24.416,500158,6651,150,842Jan 17 08:40 PM
HRUSOVSKY E KEVINChairman, President & CEOJan 15Sale22.176,500144,1301,157,342Jan 17 08:40 PM
Madaus Martin DDirectorJan 09Option Exercise1.931,6003,08811,202Jan 09 05:53 PM
Madaus Martin DDirectorJan 09Sale21.942,30050,462201,966Jan 09 05:53 PM
Madaus Martin DDirectorJan 09Sale22.331,60035,7289,602Jan 09 05:53 PM
Madaus Martin DDirectorJan 08Option Exercise1.931,6003,08811,202Jan 09 05:53 PM
Madaus Martin DDirectorJan 08Sale22.782,30052,383204,266Jan 09 05:53 PM
Madaus Martin DDirectorJan 08Sale23.151,60037,0429,602Jan 09 05:53 PM
Roskey Mark T.SVP, Commercial & AcceleratorJan 02Sale23.18461,06614,239Jan 06 04:05 PM
HRUSOVSKY E KEVINChairman, President & CEOJan 02Sale23.183,32176,9661,163,842Jan 06 04:04 PM
Mattoon DawnSr. VP, Research ProductsJan 02Sale23.181152,66522,241Jan 06 04:04 PM
Madaus Martin DDirectorDec 27Option Exercise1.931,6003,0888,149Dec 30 04:23 PM
Madaus Martin DDirectorDec 27Sale23.272,30053,523206,566Dec 30 04:23 PM
Madaus Martin DDirectorDec 27Sale23.631,60037,8066,549Dec 30 04:23 PM
Madaus Martin DDirectorDec 26Option Exercise1.931,6003,0888,149Dec 30 04:23 PM
Madaus Martin DDirectorDec 26Sale24.092,30055,408208,866Dec 30 04:23 PM
Madaus Martin DDirectorDec 26Sale24.251,60038,7956,549Dec 30 04:23 PM
Duffy David C.SVP R&D and CTODec 18Option Exercise2.286,60015,04851,360Dec 20 06:40 PM
Duffy David C.SVP R&D and CTODec 16Option Exercise1.931,6673,21746,427Dec 16 04:17 PM
Duffy David C.SVP R&D and CTODec 16Sale24.151,66740,25844,760Dec 16 04:17 PM
Madaus Martin DDirectorDec 11Option Exercise1.931,6003,0888,149Dec 11 06:48 PM
Madaus Martin DDirectorDec 11Sale25.362,30058,321211,166Dec 11 06:48 PM
Madaus Martin DDirectorDec 11Sale25.251,60040,4006,549Dec 11 06:48 PM
Madaus Martin DDirectorDec 10Option Exercise1.931,6003,0888,149Dec 11 06:48 PM
Madaus Martin DDirectorDec 10Sale25.132,30057,793213,466Dec 11 06:48 PM
Madaus Martin DDirectorDec 10Sale24.811,60039,6966,549Dec 11 06:48 PM
HRUSOVSKY E KEVINChairman, President & CEODec 02Sale25.063,35784,1361,167,163Dec 03 08:29 PM
Mattoon DawnSr. VP, Research ProductsDec 02Sale25.061152,88222,356Dec 03 08:29 PM
Roskey Mark T.SVP, Commercial & AcceleratorDec 02Sale25.06471,17814,285Dec 03 08:29 PM
Madaus Martin DDirectorNov 26Option Exercise1.931,6003,0888,149Nov 26 05:33 PM
Madaus Martin DDirectorNov 26Sale25.072,30057,660215,766Nov 26 05:33 PM
Madaus Martin DDirectorNov 26Sale25.401,60040,6406,549Nov 26 05:33 PM
Madaus Martin DDirectorNov 25Option Exercise1.931,6003,0888,149Nov 26 05:33 PM
Madaus Martin DDirectorNov 25Sale25.402,30058,425218,066Nov 26 05:33 PM
Madaus Martin DDirectorNov 25Sale24.871,60039,7886,549Nov 26 05:33 PM
Duffy David C.SVP R&D and CTONov 18Option Exercise1.931,6673,21746,427Nov 19 06:18 PM
Duffy David C.SVP R&D and CTONov 18Sale22.561,66737,61544,760Nov 19 06:18 PM
Madaus Martin DDirectorNov 13Option Exercise1.931,6003,0888,149Nov 14 04:31 PM
Madaus Martin DDirectorNov 13Sale21.782,30050,097220,366Nov 14 04:31 PM
Madaus Martin DDirectorNov 13Sale22.041,60035,2646,549Nov 14 04:31 PM
Madaus Martin DDirectorNov 12Option Exercise1.931,6003,0888,149Nov 14 04:31 PM
Madaus Martin DDirectorNov 12Sale22.232,30051,134222,666Nov 14 04:31 PM
Madaus Martin DDirectorNov 12Sale22.281,60035,6436,549Nov 14 04:31 PM
open in yahoo | open in reuters | open in google